feed,title,long_url,short_url
Benzinga,Sysco Announces Executive Leadership Changes,https://www.benzinga.com/pressreleases/20/10/g17935457/sysco-announces-executive-leadership-changes,https://j.mp/2ICBu8c
Benzinga,"HCI Group Sets Third Quarter 2020 Earnings Call for Thursday, November 5, 2020 at 4:45 p.m. ET",https://www.benzinga.com/pressreleases/20/10/g17935455/hci-group-sets-third-quarter-2020-earnings-call-for-thursday-november-5-2020-at-4-45-p-m-et,https://j.mp/31eNvHo
Benzinga,"Dupont, J&J, Philips, and More to Speak at Inaugural Virtual Engineering Week",https://www.benzinga.com/pressreleases/20/10/g17935453/dupont-j-j-philips-and-more-to-speak-at-inaugural-virtual-engineering-week,https://j.mp/3lRLVmz
Benzinga,"SUMR Brands Closes on New Credit Agreement for Future Growth, Reflecting Improved Operating Performance",https://www.benzinga.com/pressreleases/20/10/g17935451/sumr-brands-closes-on-new-credit-agreement-for-future-growth-reflecting-improved-operating-perform,https://j.mp/2GVYjTX
Benzinga,"NMI Holdings, Inc. to Host Virtual Investor Day on November 19, 2020",https://www.benzinga.com/pressreleases/20/10/g17935446/nmi-holdings-inc-to-host-virtual-investor-day-on-november-19-2020,https://j.mp/3nYHAji
Benzinga,"iCAD Hosting Technology Innovation Webinar on the Evolving Landscape for Treating Patients with Brain, Breast, and Rectal Cancers",https://www.benzinga.com/pressreleases/20/10/g17935444/icad-hosting-technology-innovation-webinar-on-the-evolving-landscape-for-treating-patients-with-br,https://j.mp/37aowIT
Benzinga,Altitude Aerospace Has Been Selected by Potez Aeronautique to Support the Engineering Development of Three Composite Doors for Eviation's All-Electric Aircraft Program - 'Alice',https://www.benzinga.com/pressreleases/20/10/n17935443/altitude-aerospace-has-been-selected-by-potez-aeronautique-to-support-the-engineering-development-,https://j.mp/3j1VvBp
Benzinga,CHMP recommends approval of DupixentÂ® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis,https://www.benzinga.com/pressreleases/20/10/g17935404/chmp-recommends-approval-of-dupixent-dupilumab-for-children-aged-6-to-11-years-with-severe-atopic-,https://j.mp/3k3gd5i
